scholarly article | Q13442814 |
P50 | author | Thumbi Ndung'u | Q1952473 |
Bruce D. Walker | Q23770361 | ||
Christina F Thobakgale-Tshabalala | Q58828199 | ||
Philip J. R. Goulder | Q72618990 | ||
Zenele Mncube | Q79068601 | ||
Mary van der Stok | Q79069730 | ||
Nasreen Ismail | Q79069804 | ||
Julia G Prado | Q90811762 | ||
Zaza M Ndhlovu | Q91595972 | ||
Catherine Koofhethile | Q100304296 | ||
Lungile Mkhize | Q117222358 | ||
P2093 | author name string | Nonhlanhla Yende | |
P2860 | cites work | Common genetic variation and the control of HIV-1 in humans | Q21092450 |
Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection | Q24564779 | ||
HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors | Q24676982 | ||
The influence of HLA genotype on AIDS | Q28202903 | ||
Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition | Q28282470 | ||
Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus | Q28302762 | ||
A combination of defective DNA and protective host factors are found in a set of HIV-1 ancestral LTNPs | Q58415384 | ||
Replication-competent HIV strains infect HIV controllers despite undetectable viremia (ANRS EP36 study) | Q61365620 | ||
Transfer of HIV-1-specific cytotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progression | Q71803154 | ||
Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS | Q73034306 | ||
AIDS restriction HLA allotypes target distinct intervals of HIV-1 pathogenesis | Q81481381 | ||
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation | Q29417018 | ||
Recovery of replication-competent HIV despite prolonged suppression of plasma viremia | Q29615995 | ||
HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells | Q29616205 | ||
Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes | Q29616210 | ||
Replicative capacity of human immunodeficiency virus type 1 transmitted from mother to child is associated with pediatric disease progression rate | Q33558599 | ||
Impaired replication capacity of acute/early viruses in persons who become HIV controllers | Q33963989 | ||
Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy. | Q34009945 | ||
Additive contribution of HLA class I alleles in the immune control of HIV-1 infection | Q34120809 | ||
Gag-protease-mediated replication capacity in HIV-1 subtype C chronic infection: associations with HLA type and clinical parameters | Q34178349 | ||
Magnitude of functional CD8+ T-cell responses to the gag protein of human immunodeficiency virus type 1 correlates inversely with viral load in plasma | Q34332166 | ||
Association between virus-specific T-cell responses and plasma viral load in human immunodeficiency virus type 1 subtype C infection | Q34465724 | ||
Limited immunogenicity of HIV CD8+ T-cell epitopes in acute Clade C virus infection | Q35164457 | ||
HIV and SIV CTL escape: implications for vaccine design | Q35852284 | ||
Elite controllers with low to absent effector CD8+ T cell responses maintain highly functional, broadly directed central memory responses | Q36086732 | ||
Maintenance of viral suppression in HIV-1-infected HLA-B*57+ elite suppressors despite CTL escape mutations | Q36238124 | ||
Human immunodeficiency virus-specific CD8+ T-cell activity is detectable from birth in the majority of in utero-infected infants | Q36315692 | ||
Immune selection for altered antigen processing leads to cytotoxic T lymphocyte escape in chronic HIV-1 infection | Q36399423 | ||
Immune escape precedes breakthrough human immunodeficiency virus type 1 viremia and broadening of the cytotoxic T-lymphocyte response in an HLA-B27-positive long-term-nonprogressing child | Q36684112 | ||
Genetic characterization of human immunodeficiency virus type 1 in elite controllers: lack of gross genetic defects or common amino acid changes | Q36845893 | ||
Functional consequences of human immunodeficiency virus escape from an HLA-B*13-restricted CD8+ T-cell epitope in p1 Gag protein. | Q37033282 | ||
HLA-A*7401-mediated control of HIV viremia is independent of its linkage disequilibrium with HLA-B*5703 | Q37081581 | ||
Pressure from TRIM5α contributes to control of HIV-1 replication by individuals expressing protective HLA-B alleles | Q37123118 | ||
HLA footprints on human immunodeficiency virus type 1 are associated with interclade polymorphisms and intraclade phylogenetic clustering | Q37157122 | ||
Impact of HLA in mother and child on disease progression of pediatric human immunodeficiency virus type 1 infection | Q37356088 | ||
HIV and HLA class I: an evolving relationship | Q38045636 | ||
Viral suppression of multiple escape mutants by de novo CD8(+) T cell responses in a human immunodeficiency virus-1 infected elite suppressor | Q38425723 | ||
First demonstration of a lack of viral sequence evolution in a nonprogressor, defining replication-incompetent HIV-1 infection | Q38451424 | ||
HLA class I-restricted T-cell responses may contribute to the control of human immunodeficiency virus infection, but such responses are not always necessary for long-term virus control | Q38610690 | ||
Gag cytotoxic T lymphocyte escape mutations can increase sensitivity of HIV-1 to human TRIM5alpha, linking intrinsic and acquired immunity | Q38959897 | ||
Widespread impact of HLA restriction on immune control and escape pathways of HIV-1 | Q41814777 | ||
Isolation and characterization of replication-competent human immunodeficiency virus type 1 from a subset of elite suppressors. | Q41827503 | ||
HIV-specific cytolytic CD4 T cell responses during acute HIV infection predict disease outcome | Q41937295 | ||
Control of HIV-1 in elite suppressors despite ongoing replication and evolution in plasma virus | Q42737606 | ||
Differential neutralization of human immunodeficiency virus (HIV) replication in autologous CD4 T cells by HIV-specific cytotoxic T lymphocytes | Q43163152 | ||
Evolution of HIV-1 in an HLA-B*57-positive patient during virologic escape. | Q44082963 | ||
Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA. | Q44291572 | ||
Long-term nonprogressive disease among untreated HIV-infected individuals: clinical implications of understanding immune control of HIV. | Q44910750 | ||
Differential selection pressure exerted on HIV by CTL targeting identical epitopes but restricted by distinct HLA alleles from the same HLA supertype. | Q53588591 | ||
CD8+ T-cell responses to different HIV proteins have discordant associations with viral load | Q57259602 | ||
P433 | issue | 15 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 6818-6831 | |
P577 | publication date | 2016-05-18 | |
P1433 | published in | Journal of Virology | Q1251128 |
P1476 | title | CD8+ T Cell Breadth and Ex Vivo Virus Inhibition Capacity Distinguish between Viremic Controllers with and without Protective HLA Class I Alleles | |
P478 | volume | 90 |
Q92781215 | Control of the HIV-1 Load Varies by Viral Subtype in a Large Cohort of African Adults With Incident HIV-1 Infection |
Q59332866 | Dual HLA B*42 and B*81-reactive T cell receptors recognize more diverse HIV-1 Gag escape variants |
Q37615584 | Factors Associated with the Size of HIV DNA Reservoir |
Q47174478 | Factors Leading to the Loss of Natural Elite Control of HIV-1 Infection. |
Q64100454 | Harnessing CD8 T Cells Under HIV Antiretroviral Therapy |
Q59349690 | Mechanisms of abrupt loss of virus control in a cohort of previous HIV controllers |
Q92538798 | The Safety and Immunogenicity of GTU®MultiHIV DNA Vaccine Delivered by Transcutaneous and Intramuscular Injection With or Without Electroporation in HIV-1 Positive Subjects on Suppressive ART |
Q40163730 | The association of HIV-1 Gag-specific IgG antibodies with natural control of HIV-1 infection in individuals not carrying HLA-B*57: 01 is only observed in viremic controllers |
Search more.